SCHEMBL8966006

SCHEMBL8966006

CCOC(=O)Nc1ccc(NCc2ccc(C(F)(F)F)cc2)cc1[N+](=O)[O-]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ2 O43526 8/20 0.58
KCNQ3 O43525 7/20 0.58
KCNQ4 P56696 4/20 0.55
KCNQ5 Q9NR82 4/20 0.55
ALDH1A1 P00352 1/20 0.49
MAPK1 P28482 2/20 0.46
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
PKM P14618 1/20 0.44
ABCB11 O95342 1/20 0.43
ESR1 P03372 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
ALOX15 P16050 1/20 0.43
NFKB1 P19838 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6004798 0.94 KCNQ2 (0.56) KCNQ2KCNQ3KCNQ4KCNQ5ALDH1A1
SCHEMBL20133927 0.89 THRB (0.53) KCNQ2KCNQ3KCNQ4KCNQ5ALDH1A1
SCHEMBL2235641 0.89 KCNQ2 (0.70) KCNQ2KCNQ3KCNQ4KCNQ5ALDH1A1
SCHEMBL6004889 0.87 THRB (0.51) KCNQ2KCNQ3KCNQ4KCNQ5KMT2A
SCHEMBL6448712 0.87 KCNQ2 (0.50) KCNQ2KCNQ3KCNQ4KCNQ5ALDH1A1
SCHEMBL8966767 0.86 KCNQ3 (0.54) KCNQ2KCNQ3KCNQ4KCNQ5ALDH1A1
SCHEMBL20134035 0.86 KCNQ3 (0.55) KCNQ2KCNQ3KCNQ4KCNQ5ALDH1A1
SCHEMBL2070590 0.85 KCNQ2 (0.65) KCNQ2KCNQ3KCNQ4KCNQ5ALDH1A1
SCHEMBL30796364 0.85 KCNQ2 (0.65) KCNQ2KCNQ3KCNQ4KCNQ5ALDH1A1
SCHEMBL3607316 0.85 KCNQ2 (0.52) KCNQ2KCNQ3KCNQ4KCNQ5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180127357-A1 (2-AMINO-4-(ARYLAMINO)PHENYL) CARBAMATES UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2018-05-10 US disclosed
EP-0554543-B1 1,2,4-Triaminobenzene derivatives and process for their preparation ASTA MEDICA AG (DE) 1996-02-28 EP disclosed
US-5384330-A Pharmaceutically active 1,2,4-triamino-benzene derivatives, processes for their preparation and pharmaceutical compositions containing them ASTA MEDICA AKTIENGESELLSCHAFT (DE) 1995-01-24 US disclosed
EP-0554543-A2 1,2,4-Triaminobenzene derivatives and process for their preparation ASTA Medica Aktiengesellschaft (DE) 1993-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127357-A1 (2-AMINO-4-(ARYLAMINO)PHENYL) CARBAMATES HRH4, H1-10, HDAC10 KCNQ2 1257/4885KCNQ3 1235/4885KCNQ4 1297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.